Compared to the individual agents, the metformin and TRAIL combination significantly inhibited colony formation in and migration of CRC cells, as well as significantly decreased Mcl-1 and Bcl-2 (anti-apoptotic proteins), and increased Bim and Puma (pro-apoptotic proteins) (Supplementary Figure S1). Here, BCL2L11 is linked to colorectal carcinoma.